| abstract |
The present invention relates to the use of benzoindazole derivative compounds, salts and solvates thereof for the manufacture of a medicament for modulating alpha2 subtype GABA A receptors. The present invention also relates to novel heterocyclic compounds and pharmaceutical compositions containing the compounds. The present invention also provides the use of a compound of formula (I), salts and solvates thereof for the manufacture of a medicament for the treatment of depression, anxiety disorders, psychotic disorders, learning or cognitive disorders, sleep disorders, convulsions or seizure disorders or pain. It is about:n n n Formula I |